OSLO, Norway--(BUSINESS WIRE)--Nordic Nanovector ASA (OSE: NANO) , a company focusing on the development and commercialization of novel targeted therapeutics in haematology and oncology, announces that its CEO Luigi Costa will present at DNB Healthcare Conference in Oslo, Norway today at 10:00 am CET. The slides of the presentation given will be available on the Nordic Nanovector website in the section: Investor Relations/Reports and Presentations/Presentations/2015. ###
